US Stocks
/
Nuvectis Pharma, Inc. Share Price

Nuvectis Pharma, Inc. Share Price

NASDAQ: NVCT | Small Cap
$18.97
-$0.53 (-2.69%) Last updated on 15 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Nuvectis Pharma, Inc. Stock Performance

Open
$19.10
Prev. Close
$19.50
Circuit Range
N/A
Day Range
$18.88 - $19.21
Year Range
$5.63 - $29.18
Volume
6,407
Average Traded
$19.03

Nuvectis Pharma, Inc. Share Price Today

As of 17 August 2026, Nuvectis Pharma, Inc.'s share price is $18.97. The stock opened at $19.10, compared to its previous close of $19.50. During today's trading session, Nuvectis Pharma, Inc.'s share price traded between $18.88 and $19.21, with an average price of $19.05. Over the past 52 weeks, the stock has recorded a high of $29.18 and a low of $5.63. In terms of performance, Nuvectis Pharma, Inc.'s share price has risen by 109.27% over the last six months and is up 190.06% on a year-on-year basis.

Nuvectis Pharma, Inc. Share Price Chart

$18.88$19.21
L
Show Current Price
H

Nuvectis Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$413.79M
PE Ratio (TTM)
-14.37
Dividend Yield
N/A
EPS (TTM)
$-1.32
Revenue (TTM)
N/A
Return On Equity (TTM)
-143.61%
Profit Margin
N/A
Debt to Equity
0.72
Quarterly Earnings Growth YoY
-79.68%

Nuvectis Pharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$4.17M-$4.43M-$4.15M-$5.33M-$6.33M-$7.46M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-6.16%6.21%-28.39%-18.79%-17.81%

Nuvectis Pharma, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
RevenueN/AN/AN/A
Net Profit-$22.26M-$19.00M-$26.44M
Net Profit MarginN/AN/AN/A
Income ChangeN/A14.65%-39.17%

About Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trial for the treatment of patients with platinum-resistant ARID1a-mutated ovarian carcinoma. The company is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Nuvectis Pharma, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$21.80
$18.97
-11.42%
Jul 2026
$18.69
$21.41
+16.80%
Jun 2026
$9.82
$18.34
+87.09%
May 2026
$8.73
$9.80
+14.35%
Apr 2026
$7.83
$8.57
+11.01%
Mar 2026
$8.96
$7.72
-14.84%
Feb 2026
$8.27
$9.06
+11.65%
Jan 2026
$7.63
$8.12
+6.34%
Dec 2025
$6.28
$7.63
+22.55%
Nov 2025
$6.63
$6.23
-7.29%
Oct 2025
$5.97
$6.72
+12.37%
Sep 2025
$6.52
$5.98
-8.56%

NVCT Share Price FAQs

What is Nuvectis Pharma, Inc. share price today?

chevron-up
Nuvectis Pharma, Inc. share price today is $18.97 as on August 15, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Nuvectis Pharma, Inc. stock?

chevron-up
The 52 week high of Nuvectis Pharma, Inc. stock is $29.18, while the 52 week low is $5.63 as of 15 Aug '26.

What is NVCT's market capitalisation today?

chevron-up
NVCT market capitalisation is $413.79M as of August 17, 2026, at 6:48 am IST.

What is NVCT's net income for the last quarter?

chevron-up
NVCT's net income for the last quarter is -0.01B USD.

What is the 5 year returns of NVCT?

chevron-up
The 5 year returns of NVCT is 176.13% as on 15 Aug '26.

What is the high & low stock price of NVCT today?

chevron-up
NVCT stock price hit a high of $19.21 and low of $18.88 as of 15 Aug '26.

Can I buy NVCT shares in India?

chevron-up
Yes. You can buy NVCT in India by opening an international trading account.